IceCure Medical Shares Outstanding 2020-2023 | ICCM
IceCure Medical shares outstanding from 2020 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| IceCure Medical Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 46 |
| 2022 | 37 |
| 2021 | 29 |
| 2020 | 17 |
| 2019 | 14 |
| IceCure Medical Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-09-30 | |
| 2023-03-31 | 46 |
| 2022-03-31 | 37 |
| 2021-12-31 | |
| 2021-09-30 | 31 |
| 2021-06-30 | |
| 2021-03-31 | 21 |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.051B | $0.003B |
| IceCure Medical Ltd. develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. IceCure Medical Ltd. is based in CAESAREA, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.258B | 15.59 |
| Cencora (COR) | United States | $44.266B | 17.26 |
| ICON (ICLR) | Ireland | $26.033B | 24.58 |
| DiDi Global (DIDIY) | China | $23.379B | 0.00 |
| Avantor (AVTR) | United States | $17.056B | 25.11 |
| CochLear (CHEOY) | Australia | $14.191B | 0.00 |
| Viatris (VTRS) | United States | $13.264B | 3.96 |
| Revvity (RVTY) | United States | $13.145B | 23.06 |
| Natera (NTRA) | United States | $12.958B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.348B | 40.62 |
| Charles River Laboratories (CRL) | United States | $11.993B | 22.96 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.923B | 0.00 |
| Solventum (SOLV) | United States | $11.243B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.782B | 0.00 |
| HealthEquity (HQY) | United States | $6.591B | 49.24 |
| Organon (OGN) | United States | $5.491B | 5.21 |
| Bausch + Lomb (BLCO) | Canada | $5.234B | 20.97 |
| Doximity (DOCS) | United States | $4.386B | 32.65 |
| PACS (PACS) | United States | $4.041B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.426B | 31.35 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Life Times (LTH) | United States | $2.939B | 30.79 |
| GoodRx Holdings (GDRX) | United States | $2.627B | 95.00 |
| Progyny (PGNY) | United States | $2.617B | 45.05 |
| AMN Healthcare Services Inc (AMN) | United States | $2.370B | 9.39 |
| Premier (PINC) | United States | $2.365B | 8.85 |
| Agilon Health (AGL) | United States | $2.262B | 0.00 |
| NovoCure (NVCR) | Jersey | $2.187B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.161B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.936B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.618B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.338B | 0.00 |
| Embecta (EMBC) | United States | $0.842B | 5.73 |
| CareDx (CDNA) | United States | $0.794B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.714B | 7.57 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.559B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.558B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.453B | 45.20 |
| Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
| LifeMD (LFMD) | United States | $0.384B | 0.00 |
| ModivCare (MODV) | United States | $0.384B | 7.18 |
| MultiPlan (MPLN) | United States | $0.364B | 0.00 |
| Beauty Health (SKIN) | United States | $0.346B | 0.00 |
| DocGo (DCGO) | United States | $0.344B | 18.33 |
| Ascend Wellness Holdings (AAWH) | United States | $0.281B | 0.00 |
| Sharecare (SHCR) | United States | $0.273B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.271B | 0.00 |
| Biodesix (BDSX) | United States | $0.171B | 0.00 |
| So-Young (SY) | China | $0.126B | 42.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.77 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |